821 related articles for article (PubMed ID: 18271619)
1. Mechanisms of GII.4 norovirus persistence in human populations.
Lindesmith LC; Donaldson EF; Lobue AD; Cannon JL; Zheng DP; Vinje J; Baric RS
PLoS Med; 2008 Feb; 5(2):e31. PubMed ID: 18271619
[TBL] [Abstract][Full Text] [Related]
2. [Noroviruses--tactic of spread].
Gospodarek E; Zalas-Wiecek P
Przegl Epidemiol; 2009; 63(1):5-9. PubMed ID: 19522218
[TBL] [Abstract][Full Text] [Related]
3. Human Norovirus Neutralized by a Monoclonal Antibody Targeting the Histo-Blood Group Antigen Pocket.
Koromyslova AD; Morozov VA; Hefele L; Hansman GS
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541855
[TBL] [Abstract][Full Text] [Related]
4. Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity.
Debbink K; Donaldson EF; Lindesmith LC; Baric RS
J Virol; 2012 Jan; 86(2):1214-26. PubMed ID: 22090110
[TBL] [Abstract][Full Text] [Related]
5. Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations.
Donaldson EF; Lindesmith LC; Lobue AD; Baric RS
Immunol Rev; 2008 Oct; 225():190-211. PubMed ID: 18837783
[TBL] [Abstract][Full Text] [Related]
6. Bile Facilitates Human Norovirus Interactions with Diverse Histoblood Group Antigens, Compensating for Capsid Microvariation Observed in 2016-2017 GII.2 Strains.
Mallory ML; Lindesmith LC; Brewer-Jensen PD; Graham RL; Baric RS
Viruses; 2020 Sep; 12(9):. PubMed ID: 32899556
[TBL] [Abstract][Full Text] [Related]
7. Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens.
Parra GI; Abente EJ; Sandoval-Jaime C; Sosnovtsev SV; Bok K; Green KY
J Virol; 2012 Jul; 86(13):7414-26. PubMed ID: 22532688
[TBL] [Abstract][Full Text] [Related]
8. Norovirus GII.4 strain antigenic variation.
Lindesmith LC; Donaldson EF; Baric RS
J Virol; 2011 Jan; 85(1):231-42. PubMed ID: 20980508
[TBL] [Abstract][Full Text] [Related]
9. Immunogenetic mechanisms driving norovirus GII.4 antigenic variation.
Lindesmith LC; Beltramello M; Donaldson EF; Corti D; Swanstrom J; Debbink K; Lanzavecchia A; Baric RS
PLoS Pathog; 2012; 8(5):e1002705. PubMed ID: 22615565
[TBL] [Abstract][Full Text] [Related]
10. Genogroup IV and VI canine noroviruses interact with histo-blood group antigens.
Caddy S; Breiman A; le Pendu J; Goodfellow I
J Virol; 2014 Sep; 88(18):10377-91. PubMed ID: 25008923
[TBL] [Abstract][Full Text] [Related]
11. Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution.
Shanker S; Choi JM; Sankaran B; Atmar RL; Estes MK; Prasad BV
J Virol; 2011 Sep; 85(17):8635-45. PubMed ID: 21715503
[TBL] [Abstract][Full Text] [Related]
12. Within-host evolution results in antigenically distinct GII.4 noroviruses.
Debbink K; Lindesmith LC; Ferris MT; Swanstrom J; Beltramello M; Corti D; Lanzavecchia A; Baric RS
J Virol; 2014 Jul; 88(13):7244-55. PubMed ID: 24648459
[TBL] [Abstract][Full Text] [Related]
13. Conservation of carbohydrate binding interfaces: evidence of human HBGA selection in norovirus evolution.
Tan M; Xia M; Chen Y; Bu W; Hegde RS; Meller J; Li X; Jiang X
PLoS One; 2009; 4(4):e5058. PubMed ID: 19337380
[TBL] [Abstract][Full Text] [Related]
14. Minimal Antigenic Evolution after a Decade of Norovirus GII.4 Sydney_2012 Circulation in Humans.
Parra GI; Tohma K; Ford-Siltz LA; Eguino P; Kendra JA; Pilewski KA; Gao Y
J Virol; 2023 Feb; 97(2):e0171622. PubMed ID: 36688654
[TBL] [Abstract][Full Text] [Related]
15. Chimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses.
Debbink K; Lindesmith LC; Donaldson EF; Swanstrom J; Baric RS
J Virol; 2014 Jul; 88(13):7256-66. PubMed ID: 24741081
[TBL] [Abstract][Full Text] [Related]
16. Human Sera Collected between 1979 and 2010 Possess Blocking-Antibody Titers to Pandemic GII.4 Noroviruses Isolated over Three Decades.
Sharma S; Carlsson B; Czakó R; Vene S; Haglund M; Ludvigsson J; Larson G; Hammarström L; Sosnovtsev SV; Atmar RL; Green KY; Estes MK; Svensson L
J Virol; 2017 Jul; 91(14):. PubMed ID: 28468886
[TBL] [Abstract][Full Text] [Related]
17. Structural analysis of determinants of histo-blood group antigen binding specificity in genogroup I noroviruses.
Shanker S; Czako R; Sankaran B; Atmar RL; Estes MK; Prasad BV
J Virol; 2014 Jun; 88(11):6168-80. PubMed ID: 24648450
[TBL] [Abstract][Full Text] [Related]
18. Genetic and phenotypic characterization of GII-4 noroviruses that circulated during 1987 to 2008.
Yang Y; Xia M; Tan M; Huang P; Zhong W; Pang XL; Lee BE; Meller J; Wang T; Jiang X
J Virol; 2010 Sep; 84(18):9595-607. PubMed ID: 20592096
[TBL] [Abstract][Full Text] [Related]
19. Norovirus GII.17 Virus-Like Particles Bind to Different Histo-Blood Group Antigens and Cross-React with Genogroup II-Specific Mouse Sera.
Malm M; Tamminen K; Vesikari T; Blazevic V
Viral Immunol; 2018 Dec; 31(10):649-657. PubMed ID: 30431404
[TBL] [Abstract][Full Text] [Related]
20. Human noroviruses' fondness for histo-blood group antigens.
Singh BK; Leuthold MM; Hansman GS
J Virol; 2015 Feb; 89(4):2024-40. PubMed ID: 25428879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
